|
1
|
Lingiah VA, Niazi M, Olivo R, Paterno F,
Guarrera JV and Pyrsopoulos NT: Liver transplantation beyond milan
criteria. J Clin Transl Hepatol. 8:69–75. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu CC, Ho WL and Liu TJ: Hepatocellular
carcinoma with adjacent organ extension: The enhancement of
preoperative transcatheter arterial embolization and the results of
surgical resection. Surg Today. 24:882–888. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grandhi MS, Kim AK, Ronnekleiv-Kelly SM,
Kamel IR, Ghasebeh MA and Pawlik TM: Hepatocellular carcinoma: From
diagnosis to treatment. Surg Oncol. 25:74–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gu J, Zhang X, Cui R, Zhang J, Wang Z, Jia
Y, Miao R, Dong Y, Ma X, Fan H, et al: Prognostic predictors for
patients with hepatocellular carcinoma receiving adjuvant
transcatheter arterial chemoembolization. Eur J Gastroenterol
Hepatol. 31:836–844. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Loosen SH, Schulze-Hagen M, Leyh C, Benz
F, Vucur M, Kuhl C, Trautwein C, Tacke F, Bruners P, Roderburg C
and Luedde T: IL-6 and IL-8 serum levels predict tumor response and
overall survival after TACE for primary and secondary hepatic
malignancies. Int J Mol Sci. 19:17662018. View Article : Google Scholar
|
|
6
|
Daniele A, Divella R, Quaranta M, Mattioli
V, Casamassima P, Paradiso A, Garrisi VM, Gadaleta CD,
Gadaleta-Caldarola G, Savino E, et al: Clinical and prognostic role
of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior
to and after trans-hepatic arterial chemo-embolization. Clin
Biochem. 47:184–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou L, Lv T, Zhang Q, Zhu Q, Zhan P, Zhu
S, Zhang J and Song Y: The biology, function and clinical
implications of exosomes in lung cancer. Cancer Lett. 407:84–92.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi X, Wang B, Feng X, Xu Y, Lu K and Sun
M: circRNAs and exosomes: A mysterious frontier for human cancer.
Mol Ther Nucleic Acids. 19:384–392. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wan M, Ning B, Spiegel S, Lyon CJ and Hu
TY: Tumor-derived exosomes (TDEs): How to avoid the sting in the
tail? Med Res Rev. 40:385–412. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han Q, Zhao H, Jiang Y, Yin C and Zhang J:
HCC-derived exosomes: Critical player and target for cancer immune
escape. Cells. 8:5582019. View Article : Google Scholar
|
|
11
|
Abudoureyimu M, Zhou H, Zhi Y, Wang T,
Feng B, Wang R and Chu X: Recent progress in the emerging role of
exosome in hepatocellular carcinoma. Cell Prolif. 52:e125412019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sarnow P and Sagan SM: Unraveling the
mysterious interactions between hepatitis C virus RNA and
liver-specific microRNA-122. Annu Rev Virol. 3:309–332. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li B, Mao R, Liu C, Zhang W, Tang Y and
Guo Z: LncRNA FAL1 promotes cell proliferation and migration by
acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells.
Life Sci. 197:122–129. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Fan L, Yu H, Zhang J, He Y, Feng D,
Wang F, Li X, Liu Q, Li Y, et al: Endoplasmic reticulum stress
causes liver cancer cells to release exosomal miR-23a-3p and
up-regulate programmed death ligand 1 expression in macrophages.
Hepatology. 70:241–258. 2019.PubMed/NCBI
|
|
15
|
Huang XY, Huang ZL, Huang J, Xu B, Huang
XY, Xu YH, Zhou J and Tang ZY: Exosomal circRNA-100338 promotes
hepatocellular carcinoma metastasis via enhancing invasiveness and
angiogenesis. J Exp Clin Cancer Res. 39:202020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su Y, Lv X, Yin W, Zhou L, Hu Y, Zhou A
and Qi F: CircRNA Cdr1as functions as a competitive endogenous RNA
to promote hepatocellular carcinoma progression. Aging (Albany NY).
11:8182–8203. 2019.
|
|
17
|
Wang G, Liu W, Zou Y, Wang G, Deng Y, Luo
J, Zhang Y, Li H, Zhang Q, Yang Y and Chen G: Three isoforms of
exosomal circPTGR1 promote hepatocellular carcinoma metastasis via
the miR449a-MET pathway. EBioMedicine. 40:432–445. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang H, Deng T, Ge S, Liu Y, Bai M, Zhu
K, Fan Q, Li J, Ning T, Tian F, et al: Exosome circRNA secreted
from adipocytes promotes the growth of hepatocellular carcinoma by
targeting deubiquitination-related USP7. Oncogene. 38:2844–2859.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang X, Zhang X, Wang G, Wang L, Lin Y and
Sun F: Hsa-miR-513b-5p suppresses cell proliferation and promotes
P53 expression by targeting IRF2 in testicular embryonal carcinoma
cells. Gene. 626:344–353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin W, Ye H, You K and Chen L:
Up-regulation of circ_LARP4 suppresses cell proliferation and
migration in ovarian cancer by regulating miR-513b-5p/LARP4 axis.
Cancer Cell Int. 20:52020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stark AL, Delaney SM, Wheeler HE, Im HK
and Dolan ME: Functional consequences of PRPF39 on distant genes
and cisplatin sensitivity. Hum Mol Genet. 21:4348–4355. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
National Health and Family Planning
Commission, . Notice of general office of national health and
family planning commission on printing and issuing standards for
diagnosis and treatment of primary liver cancer (2017 edition).
http://www.nhfpc.gov.cn/yzygj/s7659/201706/80abf02a86c048fcd130e5e298f7aeee.shtmlJune
2–2017
|
|
23
|
Kim KM, Shim SG, Sinn DH, Song JE, Kim BS
and Kim HG: Child-Pugh, MELD, MELD-Na, and ALBI scores: Which liver
function models best predicts prognosis for HCC patient with
ascites? Scand J Gastroenterol. 55:951–957. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li K, Gao B, Li J, Chen H, Li Y, Wei Y,
Gong D, Gao J, Zhang J, Tan W, et al: ZNF32 protects against
oxidative stress-induced apoptosis by modulation C1QBP
transcription. Oncotarget. 6:38107–38126. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Ao J, Li K, Zhang J, Li Y, Zhang L,
Wei Y, Gong D, Gao J, Tan W, et al: ZNF32 contributes to the
induction of multidrug resistance by regulating TGF-β receptor 2
signaling in lung adenocarcinoma. Cell Death Dis. 7:e24282016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang H, Lu Z and Zhao X: Tumorigenesis,
diagnosis, and therapeutic potential of exosomes in liver cancer. J
Hematol Oncol. 12:1332019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He X, Yu J, Xiong L, Liu Y, Fan L, Li Y,
Chen B, Chen J and Xu X: Exosomes derived from liver cancer cells
reprogram biological behaviors of LO2 cells by transferring
Linc-ROR. Gene. 719:1440442019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang G, Zhao W, Wang H, Qiu G, Jiang Z,
Wei G and Li X: Exosomal miR-744 inhibits proliferation and
sorafenib chemoresistance in hepatocellular carcinoma by targeting
PAX2. Med Sci Monit. 25:7209–7217. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wakana H, Kono H, Fukushima H, Nakata Y,
Akazawa Y, Maruyama S, Hagio K, Fujii H and Ichikawa D: Effects of
medium-chain triglycerides administration in chemically-induced
carcinogenesis in mice. Anticancer Res. 39:6653–6660. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Lu J, Dolezal J, Kulkarni S, Zhang
W, Chen A, Gorka J, Mandel JA and Prochownik EV: Inhibition of
hepatocellular carcinoma by metabolic normalization. PLoS One.
14:e02181862019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sakurai Y, Kubota N, Takamoto I, Obata A,
Iwamoto M, Hayashi T, Aihara M, Kubota T, Nishihara H and Kadowaki
T: Role of insulin receptor substrates in the progression of
hepatocellular carcinoma. Sci Rep. 7:53872017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J, Rajasekaran M, Xia H, Zhang X,
Kong SN, Sekar K, Seshachalam VP, Deivasigamani A, Goh BK, Ooi LL,
et al: The microtubule-associated protein PRC1 promotes early
recurrence of hepatocellular carcinoma in association with the
Wnt/β-catenin signalling pathway. Gut. 65:1522–1534. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hou C, Guo D, Yu X, Wang S and Liu T:
TMT-based proteomics analysis of the anti-hepatocellular carcinoma
effect of combined dihydroartemisinin and sorafenib. Biomed
Pharmacother. 126:1098622020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao D, Wang Y, Li D and Wang L:
Reconstruction and analysis of the differentially expressed
IncRNA-miRNA-mRNA network based on competitive endogenous RNA in
hepatocellular carcinoma. Crit Rev Eukaryot Gene Expr. 29:539–549.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou ZR, Liu M, Lu HR, Li YF, Liang SX and
Zhang CY: Validation of different staging systems for
hepatocellular carcinoma in a cohort of 249 patients undergoing
radiotherapy. Oncotarget. 8:46523–46531. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
de Freitas LB, Longo L, Santos D,
Grivicich I and Álvares-da-Silva MR: Hepatocellular carcinoma
staging systems: Hong Kong liver cancer vs Barcelona clinic liver
cancer in a Western population. World J Hepatol. 11:678–688. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bird TG, Dimitropoulou P, Turner RM, Jenks
SJ, Cusack P, Hey S, Blunsum A, Kelly S, Sturgeon C, Hayes PC and
Bird SM: Alpha-fetoprotein detection of hepatocellular carcinoma
leads to a standardized analysis of dynamic AFP to improve
screening based detection. PLoS One. 11:e01568012016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lian YF, Li SS, Huang YL, Wei H, Chen DM,
Wang JL and Huang YH: Up-regulated and interrelated expressions of
GINS subunits predict poor prognosis in hepatocellular carcinoma.
Biosci Rep. 38:BSR201811782018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lu SX, Zhang CZ, Luo RZ, Wang CH, Liu LL,
Fu J, Zhang L, Wang H, Xie D and Yun JP: Zic2 promotes tumor growth
and metastasis via PAK4 in hepatocellular carcinoma. Cancer Lett.
402:71–80. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhu P, Wang Y, He L, Huang G, Du Y, Zhang
G, Yan X, Xia P, Ye B, Wang S, et al: ZIC2-dependent OCT4
activation drives self-renewal of human liver cancer stem cells. J
Clin Invest. 125:3795–3808. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cho HK, Kim SY, Kyaw YY, Win AA, Koo SH,
Kim HH and Cheong J: HBx induces the proliferation of
hepatocellular carcinoma cells via AP1 over-expressed as a result
of ER stress. Biochem J. 466:115–121. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ying H, Xu Z, Chen M, Zhou S, Liang X and
Cai X: Overexpression of Zwint predicts poor prognosis and promotes
the proliferation of hepatocellular carcinoma by regulating
cell-cycle-related proteins. Onco Targets Ther. 11:689–702. 2018.
View Article : Google Scholar : PubMed/NCBI
|
